C L Amling
Overview
Explore the profile of C L Amling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wadhwa H, Terris M, Aronson W, Kane C, Amling C, Cooperberg M, et al.
Prostate Cancer Prostatic Dis
. 2016 Oct;
19(4):423-428.
PMID: 27698440
Background: Approximately 29-38% of all positive surgical margins (PSMs) at radical prostatectomy (RP) involve the apex. The prognostic significance of apical PSM remains unclear. We therefore compared the long-term oncologic...
2.
Vidal A, Howard L, Sun S, Cooperberg M, Kane C, Aronson W, et al.
Prostate Cancer Prostatic Dis
. 2016 Oct;
20(1):72-78.
PMID: 27698439
Background: At the population level, obesity is associated with prostate cancer (PC) mortality. However, few studies analyzed the associations between obesity and long-term PC-specific outcomes after initial treatment. Methods: We...
3.
Howard L, De Hoedt A, Aronson W, Kane C, Amling C, Cooperberg M, et al.
Prostate Cancer Prostatic Dis
. 2016 Jul;
19(4):380-384.
PMID: 27377207
Background: Skeletal-related events (SREs) including pathologic fracture, spinal cord compression, radiation to bone and surgery to bone, are common in men with bone metastatic castration-resistant prostate cancer (mCRPC). Men with...
4.
Moreira D, Howard L, Sourbeer K, Amarasekara H, Chow L, Cockrell D, et al.
Prostate Cancer Prostatic Dis
. 2015 Jul;
18(4):333-7.
PMID: 26171882
Background: To evaluate PSA levels and kinetic cutoffs to predict positive bone scans for men with non-metastatic castration-resistant prostate cancer (CRPC) from the Shared Equal Access Regional Cancer Hospital (SEARCH)...
5.
Cowan N, Chen Y, Downs T, Bochner B, Apolo A, Porter M, et al.
Adv Urol
. 2014 Jul;
2014:746298.
PMID: 24982672
Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low. The aims of our study...
6.
Moreira D, Cooperberg M, Howard L, Aronson W, Kane C, Terris M, et al.
Prostate Cancer Prostatic Dis
. 2014 Jan;
17(1):91-6.
PMID: 24418913
Background: To evaluate the factors associated with positive bone scans after biochemical recurrence (BCR) following radical prostatectomy in both hormone-naive subjects and subjects after androgen-deprivation therapy (ADT). Methods: Retrospective analysis...
7.
Allott E, Abern M, Gerber L, Keto C, Aronson W, Terris M, et al.
Prostate Cancer Prostatic Dis
. 2013 Oct;
16(4):391-7.
PMID: 24100644
Background: While epidemiologic studies suggest that metformin use among diabetics may decrease prostate cancer (PC) incidence, the effect of metformin use on PC outcome is unclear. We investigated the association...
8.
Whitley B, Moreira D, Thomas J, Aronson W, Terris M, Presti Jr J, et al.
Prostate Cancer Prostatic Dis
. 2011 Sep;
14(4):361-6.
PMID: 21894174
Background: We examined the relationship between weight change in the year before radical prostatectomy (RP) and biochemical recurrence (BCR) and adverse pathology. Methods: We abstracted data from 359 men undergoing...
9.
Banez L, Loftis R, Freedland S, Presti Jr J, Aronson W, Amling C, et al.
Prostate Cancer Prostatic Dis
. 2010 Mar;
13(2):173-7.
PMID: 20195294
Prostate growth is dependent on circulating androgens, which can be influenced by hepatic function. Liver disease has been suggested to influence prostate cancer (CaP) incidence. However, the effect of hepatic...
10.
Moreira D, Presti Jr J, Aronson W, Terris M, Kane C, Amling C, et al.
Prostate Cancer Prostatic Dis
. 2009 Nov;
13(1):87-93.
PMID: 19918263
To evaluate whether race modifies the accuracy of nomograms to predict biochemical recurrence (BCR) after radical prostatectomy among subjects from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke...